Cilazapril

Cilazapril is an angiotensin-converting enzyme inhibitor (ACE inhibitor) that is used for the treatment of hypertension and congestive heart failure. It was patented in 1980 and came into medical use in 1988. Cilazapril is available in countries such as Switzerland, Italy, and New Zealand.

Etymology[edit | edit source]

The name "Cilazapril" is derived from the systematic (IUPAC) name which is (2S,4S)-1-[[2-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid, 1-ethyl ester. The "Cila" part of the name is taken from the first four letters of the company that first synthesized it, Cilag. The "pril" ending is a common ending for ACE inhibitors.

Medical Uses[edit | edit source]

Cilazapril is used for the treatment of hypertension and congestive heart failure. It works by inhibiting the angiotensin-converting enzyme which is involved in the regulation of blood pressure.

Side Effects[edit | edit source]

Common side effects of Cilazapril include dizziness, headache, fatigue, and cough. Serious side effects may include angioedema, kidney problems, and high blood potassium.

Related Terms[edit | edit source]

See Also[edit | edit source]

Cilazapril Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.